Where there is risk there is reward and nowhere does this apply more than to biotechnology companies. Mark Dunne puts the sector under the microscope and discovers a quintet of portfolio-enhancing firms.
Shares Magazine
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of directors' buys and sells
- Articles from Shares magazine
